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Copyright © 2008 AHC The γ subunit (FXYD2) of Na,K-ATPase is an important regulator of the sodium pump. In
this investigation we have analysed the trafficking of γ to the plasma membrane in cultures
of inner medullary collecting duct cells (IMCD3) following acute hypertonic challenge and
brefeldin A (BFA) treatment. Following hypertonic challenging for 24 hr immunofluorescence
labeling revealed initial co-localization of the γ subunit and 58K Golgi protein in the cyto-
plasm, but no co-localization of α1 and Golgi protein. Exposure of the challenged cells to
BFA prevented the subsequent incorporation of γ into the basolateral plasma membrane.
The  γ subunit instead remained in cytoplasmic vesicles while cell proliferation and cell
viability decreased simultaneously. Following removal of BFA from the hypertonic medium
the IMCD3 cells recovered with distinct expression of γ in the basolateral membrane. The
α1 subunit was only marginally influenced by BFA. The results demonstrate that the γ
subunit trafficks to the plasma membrane via the Golgi apparatus, despite the absence of a
signal sequence. The results also suggest that the γ and α subunits do not traffic together
to the plasma membrane, and that the γ and α subunit have different turnover rates during
these experimental conditions.
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I. Introduction
The Na,K-ATPase is made up of α and β subunits and
in renal tissue also a small, single-span ca 7 kD γ subunit
(FXYD2) [33]. All three subunits together form the enzyme
complex in most parts of the nephron, including the princi-
pal cells in the collecting ducts at the tip of the papilla
(IMCD3 cells) [24, 30, 32, 35]. However, the γ subunit is ab-
sent in immortalized murine cells originating from IMCD3
cells cultured under isotonic conditions, but becomes strong-
ly expressed in the basolateral plasma membrane by acute
hypertonicity [7, 8, 29]. The cellular pathway of γ to the
cell membrane has not been clarified, and it is not known
whether γ is transported to the basolateral membrane alone
or together with αβ heterodimers. The protein domains
responsible for the polarized sorting of transport proteins
have been intensely investigated [e.g. 12, 27], but as recently
pointed out [6] surprisingly little is still known about the
targeting and trafficking of the Na,K-ATPase to the baso-
lateral surface. Both the α and β subunits are assembled
at the level of the ER [1, 17, 18, 25], but if the α subunit is
expressed alone it is retained and degraded in the endo-
plasmic reticulum, while the β subunit is able to traffick
alone to the plasma membrane [10, 16]. It is likely that
the γ subunit becomes synthesized and transported to the
basolateral membrane along the same route as the mature
α and β subunits, but it has also been expressed alone on
the apical surface of mouse blastocysts [20]. Furthermore
the γ subunit has no N-terminal signal sequence [24], in
contrast to the five other FXYD proteins [11, 13, 15].
The aim of this paper was to obtain information about
the trafficking of γ in IMCD cells following hypertonic chal-
lenging specifically as related to the α subunit. To interfere
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plied brefeldin A (BFA), which is known to influence the
protein secretory pathways generally in eukaryotes [14, 21,
34, 36]. The results suggest that the γ subunit transits alone,
separate from α1, through the Golgi apparatus and then
trafficks to the basolateral membrane to become assembled
with the Na,K-ATPase αβ-heterodimer.
II. Materials and Methods
Cell cultures
The 300 mOsm/kgH2O medium was prepared by
mixing D-MEM and F-12 nutrient solutions at 1:1 supple-
mented with 10% fetal bovine serum, 100 U/ml penicillin,
and 100 μg/ml streptomycin. Immortalized murine IMCD3
cells, kindly provided by Dr. C. J. Rivard (University of
Colorado Health Science Center, Denver, CO), were
propagated in the 300 mOsm/kgH2O medium and acutely
challenged with a 550 mOsm/kgH2O medium to induce γ
synthesis by addition of 5 M NaCl according to Capasso
et al. [7, 8]. Media were routinely changed every 24 hr in
each experiment.
Reagents and antibodies
Stock solution of Brefeldin A (Sigma-Aldrich Den-
mark, Vallensbæk Strand, Denmark), was made up as 10
mM in methanol and stored at −20°C. Polyclonal rabbit
antibodies against the COOH terminus of the γ subunit of
Na,K-ATPase and corresponding purified peptide were
kindly provided by Dr. Steven Karlish (The Weizmann Insti-
tute of Science, Rehovot, Israel). Monoclonal antibodies
against the 58K Golgi protein were obtained from Sigma-
Aldrich (Sigma-Aldrich Denmark A/S, Vallensbæk Strand,
Denmark). The 58K protein antibody recognizes an epitope
on a 58KDa protein (formiminotransferase cyclodeaminase)
located on the peripheral Golgi membrane [4]. Monoclonal
GM 130 antibodies, which recognize a 130 kDa Golgi
matrix protein associated with the cis-compartment of the
Golgi apparatus, were obtained from BD Biosciences Labo-
ratories (Brødby, Denmark). To-Pro-3 (Molecular Probes,
Invitrogen A/S, Taastrup, Denmark) was used as a nuclear
counterstain.
Experimental protocols
Protocol 1
Experimental cell cultures were exposed to 1 μM
(0.28 μg/ml) or 5 μM brefeldin A (BFA) (1.4 μg/ml) in
hypertonic 550 mOsm/kgH2O medium. Control cultures
were grown in hypertonic or isotonic media without BFA.
Some cultures were allowed to continue to grow in hyper-
tonic medium after BFA treatment to follow recovery of
the IMCD3 cells.
Protocol 2
Cell cultures were first challenged with hypertonic 550
mOsm/kgH2O medium and subsequently exposed to 1 μM
or 5 μM BFA solution in hypertonic medium. Control cul-
tures were grown either in hypertonic or iso-osmotic media
without BFA for equivalent times, and some cultures were
allowed to continue to grow in hypertonic medium without
BFA to follow recovery of the IMCD3 cells.
Cell counting and cell proliferation
For cell counting 0.5 ml of 0.4% trypan blue, 0.3 ml of
culture medium and 0.1 ml of cell suspension were mixed in
an eppendorf tube. After 5 min the hemocytometer counting
chambers were loaded and viable cells (unstained) were
counted from five squares in each chamber. Average num-
bers from three wells were used for cell proliferation graphs.
From the IMCD3 cell suspension 10,000 cells were seeded
in each well on two 24-well plates (Corning, Inc., NY, USA)
with one ml of 300 mOsm/kgH2O medium. After 24 hr
cells from 3 wells were split, counted and this time point
taken as zero. Cells on one plate continued to grow in 300
mOsm/kgH2O medium, and cells on the other plate were
challenging with the 550 mOsm/kgH2O medium. Cell
numbers from 3 wells from each plate were counted every
24 hr up to 168 hr.
Cell viability
Initially 10,000 or 25,000 cells were seeded per well on
24-well-cell culture plate. Viability of IMCD3 cells was
measured using CellTiter 96 Aqueous Non-radioactive Cell
Proliferation Assay (Promega, Ramcon, Birkerød, Den-
mark). The absorbance of the colored reaction product,
formazan, was measured at 490 nm and is directly pro-
portional to the number of living cells in the culture. Cell
viabilities from isotonic 300 mOsm/kgH2O medium and
cultures acutely challenged with 550 mOsm/kgH2O were
compared with the corresponding values of cell cultures
treated with BFA.
Immunofluorescence microscopy and confocal laser 
scanning microscopy
Cells were grown on cover glasses in 24-well plates
until subconfluent and then treated with hypertonic medi-
um with or without BFA for 24 or 48 hr. Cells were then
rinsed with PBS with an osmolality corresponding to the
osmolality of the growth medium before fixation with 4%
paraformaldehyde (PFA) in isotonic or hypertonic PBS for
10 min. Permeabilization, blocking of unspecific binding
sites and incubation with primary and secondary antibodies
were performed as described previously [29]. Cell cultures
prepared for immunofluorescence microscopy were ana-
lyzed by confocal laser scanning microscopy as previously
described [29].
Data analysis
Statistical analyses of differences between curves were
performed using stratified Wilcoxon test (van Eltern test)
and for cell viability Mann-Whitney non-parametric test.
Data were expressed as means±SE. Differences were con-
sidered significant for values of p<0.05 (*), p<0.01 (**) or
p<0.001 (***).BFA Blocks γ Subunit Traffick to Cell Membrane 107
III. Results
Hypertonicity and BFA decrease cell proliferation and 
viability
IMCD3 (inner medullary collecting duct) cell prolifer-
ation for 168 hr was approximately exponential in isotonic
medium (300 mOsm/kgH2O), and following acute challenge
to hypertonic medium (550 mOsm/kgH2O), (Fig. 1A). How-
ever, the proliferation rate of challenged cells in hypertonic
medium was significantly slower than the proliferation rate
of IMCD3 cells in isotonic medium.
In the hypertonic medium in the presence of 1 μM BFA
(Protocol 1) the number of IMCD3 cells decreased signifi-
cantly (p<0.001) during the first 24 hr, but removal of BFA
from the hypertonic medium (the recovery period) induced
slow cell proliferation (p<0.001) (Fig. 1B). Treatment with 5
μM BFA caused the cell numbers to decrease during the
whole period illustrating cell death also after removal of the
drug (Fig. 1B). The effect of BFA on cell viability based
using the non-radioactive cell viability test was the same
with 10,000 and 25,000 cells and cell viability was signifi-
cantly decreased (p<0.05) with 1 μM BFA in the hypertonic
medium (Fig. 1C).
Brefeldin A inhibits transport of γ to the plasma membrane 
(Protocol 1)
The Golgi proteins, 58K and GM130, were strongly ex-
pressed in all IMCD3 cells growing in 300 mOsm/kgH2O
medium (Fig. 2A and B), but the γ subunit was totally absent
(Fig. 2B). GM130 was expressed as several small vesicles
Fig. 1. A: IMCD3 cell proliferation is retarded in hypertonic media.
Cells were seeded in two 24-well plates in 300 mOsm/kgH2O
medium at a concentration of 10,000 cells/well. After subconflu-
ences, 3 wells in each plate were counted at the starting point (0 hr)
and daily up to 168 hr. Cells on one plate continued to grow in
300 mOsm/kgH2O medium, while cells on the other plate were
challenged with hypertonic 550 mOsm/kgH2O medium, which
significantly retarded cell proliferation. B: IMCD3 cell prolifera-
tion is retarded with BFA. IMCD3 cells were seeded on two 24-
well plates at a concentration of 200,000 cells/well. When the cells
were subconfluent, the cell numbers were counted and this time
was defined as the starting point (0 hr). The wells were then
divided into 4 groups with different media: 300 mOsm/kgH2O, 550
mOsm/kgH2O, 550 mOsm/kgH2O+1 μM BFA, 550 mOsm/kgH2O+
5 μM BFA. Cell numbers were determined after 24 hr and BFA-
media were changed to BFA-free media for another 48 hr. All
pairwise comparisons between the curves are significantly differ-
ent (p<0.001) and illustrate that BFA causes distinct decreases in
cell proliferation. C: Cell viability decreases after treatment with
BFA. IMCD3 cells were seeded on two 24-well plates at a con-
centration of 10,000 or 25,000 cells/well. When the cells were sub-
confluent, 3 wells were split, the number of cells counted, and this
time determined as the starting point. The IMCD3 cell viability
based on the non-radioactive cell viability test decreased following
BFA treatment both in 300 and 550 mOsm/kgH2O media. Graphs
in all figures show mean values±SE.Pihakaski-Maunsbach et al. 108
and short cisternae (Fig. 2A), while 58K Golgi protein ap-
peared mainly as larger but fewer cisternal and vesicular
complexes (Fig. 2B). The expression of GM130 in IMCD3
cells acutely challenged in the hypertonic medium for 24 hr
was similar or sometimes even stronger than in IMCD3 cells
grown in 300 mOsm medium (Fig. 2C, cf. Fig. 2A).
The role of the Golgi apparatus in the transport of the γ
subunit to the plasma membrane was studied in IMCD3 cells
treated with BFA according to protocols 1 and 2. The γ sub-
unit (green) was strongly expressed in the plasma membrane
of groups of hypertonically challenged IMCD3 control cells
(Fig. 3A), but only faintly expressed in some cells if the me-
dium contained BFA (Fig. 3B). However, if BFA was then
excluded from the medium and the cells recovered for 48 hr
in hypertonic medium only, γ expression was distinctly en-
hanced. Thus γ was observed in larger groups of cells than
after challenging in medium without BFA (compare Fig. 5E
and 5G). High magnification images showed that the γ label
(green) was present both in the plasma membrane and in the
Golgi region of some cells (Fig. 3D, arrows), while 58K
Golgi protein (red) was present in all cells (Fig. 3E). Double
immunolabeling for γ and 58K Golgi protein revealed strong
co-localization in the perinuclear cytoplasm in merged
images (arrows in Fig. 3F). BFA treatment decreased γ
labeling of the plasma membrane, as well as 58K Golgi
protein (Fig. 3G–I). Double labeling with γ (Fig. 3J) and
58K Golgi protein (Fig. 3K) showed return of both proteins
to the Golgi regions after recovery for 48 hr (Fig. 3L,
arrows). Treatment with 5 μM BFA for 24 hr together with
hypertonic challenging caused extensive cell death and the
remaining cells showed disassembly of the Golgi appara-
tus and absence of the γ subunit in the plasma membrane
(results not shown).
The immunolabeling of the α1 subunit after hypertonic
challenging for 24 hr was only observed in the plasma mem-
brane but not in the cytoplasm (Fig. 4A). It also remained in
the plasma membrane after BFA treatment (Fig. 4B). There
was no apparent co-localization of α1 with the 58K Golgi
protein (Fig. 4C–F).
Localization of γ and α after hypertonic challenge and 
subsequent BFA treatment (Protocol 2)
The number of γ labeled cells was increased in groups
of cells in cultures challenged with 550 mOsm/kgH2O medi-
Fig. 2. Localization of Golgi proteins in IMCD3 cells. Immunolocalization of Golgi proteins GM130 (A, C) and Golgi 58k (B) in IMCD3 cells,
cultured in isotonic medium, and acutely challenged with 550 mOsm/kgH2O medium (C). In 300 mOsm/kgH2O medium both the GM130
protein (green) (A) and 58k protein (red) (B) are strongly expressed in the Golgi apparatus located close to the nucleus. Nuclei are stained with
To-Pro-3. Bar=20 μm.
Fig. 3. Simultaneous acute hypertonic challenge and BFA treatment redistributes Na,K-ATPase γ subunit and Golgi proteins in IMCD3 cells.
Over-view images (A–C) and high magnification images (F, I and L) of double-immunolocalized 58K Golgi protein and the γ subunit of Na,K-
ATPase in the cytoplasm of IMCD3 cells acutely challenged for 24 hr with 550 mOsm/kgH2O medium (A and F), simultaneously treated with
1 μM brefeldin A (BFA) (B and I), and subsequently again in 550 mOsm/kgH2O without BFA (C and L). The γ subunit is strongly expressed in
the plasma membrane in clusters of challenged cells (green) (A), very little or not at all expressed in BFA treated cells (B) but again intensely
expressed in large clusters of cells during a recovery period in hypertonic medium without BFA treatment (C). This is further demonstrated in
high magnification single color and overlay images: A stripe of cells with γ label (green) in the plasma membrane as well as in the cytoplasm of
the same IMCD cells (arrows, D). 58K Golgi protein labeling (red) is present in all cells. Golgi areas in the γ-positive cells marked with arrows
(E). Co-localization (yellow) in the γ-positive cells in a merged image (arrows, F). In the BFA treated cells γ is lacking in the plasma membrane
but is present differently in the cytoplasm of some cells (arrows, G). The expression of 58K Golgi protein is diminished and diffuse in the cyto-
plasm (H) and co-localizes with γ in overlays (arrows, I). The γ subunit is strongly expressed in the plasma membrane of cells recovered from
the BFA treatment in the hypertonic medium for 48 hr and expressed also in the cytoplasm (J). These cytoplasmic areas are also labeled for
Golgi 58K and show resemblance to the Golgi apparatus (K, red) and are co-localizing with the γ label (L, arrows). Nuclei are stained with To-
Pro-3. Bars=40 μm (A), 15 μm (B). Magnification is the same in A–C, and D–L, respectively.BFA Blocks γ Subunit Traffick to Cell Membrane 109
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um for 48 hr (Fig. 5A, B, cf. Fig. 3A). Cells challenged first
for 24 hr and subsequently exposed to 1 μM BFA in hyper-
tonic medium for 24 hr (Fig. 5C, D), showed, on the con-
trary, diffuse and vesicular cytoplasmic γ label but no label
of the plasma membrane (Fig. 5, cf. A vs. C, and B vs. D).
Some of the vesicles were arranged like pearls in a necklace
in the periphery of the cells (Fig. 5D, arrows). Interestingly,
the proportion of cells labeled for γ in cell cultures exposed
Fig. 4. Simultaneous acute hypertonic challenge and BFA treatment does not redistribute Na,K-ATPase α1 subunit. Hypertonically challenged
(A, C and E) and simultaneously BFA-treated (B, D and F) IMCD3 cells with double-immunostaining for the α1 subunit of Na,K-ATPase
(green, A and B) and the 58K Golgi protein (red, C and D) show no co-localization in the overlay images (E and F). Immunolabeling for the α1
subunit in the plasma membrane remains strong after BFA treatment (B). The 58K Golgi protein label is visible in all control cells (C) but only
in a few experimental cells (arrows, D). Cell nuclei are stained with To-Pro-3. Same magnification in all images. Bar=15 μm.BFA Blocks γ Subunit Traffick to Cell Membrane 111
Fig. 5. Effect of acute hypertonic challenge and consecutive BFA treatment vs. hypertonic challenge without BFA on the location of Na,K-
ATPase γ subunit. Immunolocalization of the γ subunit shows strong plasma membrane staining in IMCD3 cells acutely challenged in 550
mOsm/kgH2O medium for 48 hr (control) (A) and at higher magnification (B). First hypertonic challenging (24 hr) and then 1 μM BFA in 550
mOsm/kgH2O medium (24 hr) results in absence of γ from the plasma membrane but diffuse or vesicular labeling in the cytoplasm (C and D).
In some cells small vesicles are located like pearls in string close to the plasma membrane (arrows, D). Continuous hypertonic challenging for 4
d without BFA does not induce more γ-stained cells than cultures challenged for two days (E cf. A) but indicates strong plasma membrane loca-
tion (F). The ability of cells to recover after the 1 μM BFA treatment is demonstrated in G and H. Cells received the same BFA treatment as in
C and D, but were then incubated in 550 mOsm/kgH2O medium for 48 hr without BFA (G). The γ subunit is observed in more cells than in the
cultures that have been in hypertonic medium only for four days (E). High magnification image (H) demonstrates that γ is present both in the
plasma membranes and in the cytoplasm. Cell nuclei are stained blue with To-Pro-3. Magnification is the same in A, C, E and G; bar in A=40
μm. Magnification is the same in B, F and H; bar in B=20 μm. Bar in D=10 μm.Pihakaski-Maunsbach et al. 112
to hypertonic medium for 96 hr without BFA treatment
(Fig. 5E, F) was not greater than in cell cultures grown in the
same medium for 48 hr only (Fig. 5E vs. A) or in cell cul-
tures that had been treated with BFA (Fig. 5G, H).
Double immunolabelings for the α1 and γ subunits
showed that α1 was distinctly present in the plasma
membrane of all hypertonically challenged IMCD3 cells
(Fig. 6A), while γ was present only in some of the chal-
lenged cells (Fig. 6B, cells without γ marked with stars in
A). After exposure of cell cultures to BFA for 24 hr in hyper-
tonic medium the α1 remained in the plasma membrane
although somewhat reduced (Fig. 6C). The γ subunit was
Fig. 6. Different responses of Na,K-ATPase α1 and γ subunits in hypertonic challenged IMCD3 cells with or without BFA treatment. Immu-
nolocalization after acute hypertonic challenge of IMCD3 cells for 48 hr with the monoclonal antibody against the α1 subunit demonstrates uni-
form location of α1 in the plasma membranes of all cells, while only a portion of cells (γ-negative cells marked with stars in A) shows
immunolocalization with polyclonal antibody against the Na,K-ATPase γ subunit (B). Hypertonic challenging for 24 hr and then BFA in a
hypertonic medium for 24 hr results in distinct location of α1 (C) in the plasma membrane in most cells and additional weak diffuse location in
the cytoplasm, while γ is almost exclusively located diffusely in the cytoplasm of some cells (D). IMCD3 cells in (E) and (F) immunostained for
α1 and γ, respectively, were treated as in C and D but subsequently allowed to recover in 550 mOsm/kgH2O medium without BFA for 48 hr.
Similar location of α1 in the plasma membrane as in control (E cf. A), while γ is located both in the plasma membrane but still also diffusely in
the cytoplasm (F). Cell nuclei are stained blue with To-Pro-3. Magnification is the same in all images. Bar=20 μm.BFA Blocks γ Subunit Traffick to Cell Membrane 113
almost exclusively present in the cytoplasm (Fig. 6D). Fol-
lowing a recovery period for 48 hr without BFA in the
hypertonic medium α1 was as before strongly expressed in
the plasma membrane of all cells (Fig. 6E), while γ was
present both in the plasma membrane and in the cytoplasm.
IV. Discussion
The present immunocytochemical observations suggest
that  γ is not transported together with α1 to the plasma
membrane during hypertonic challenging of IMCD3 cells.
Immunolabeling for α1 overlaps neither with γ nor with
Golgi marker 58K protein at the time points, when γ is over-
lapping with the Golgi marker. This probably also excludes
the possibility that γ trafficks together with αβ hetero-
dimers after co-translational synthesis of α and β subunits
in the ER [16, 25, 26].
Our previous immunofluorescence observations indi-
cated that biosynthesis of γ after hypertonic challenging is
slow and that the subunit is detectable in the cytoplasm of
IMCD3 cells only after 6 hr and distinctly in the plasma
membrane after 24 hr [29]. This is consistent with the ob-
served doubling time of about 18 hr for the γ subunit of
IMCD3 cells in 600 mOsm/kgH2O medium reported by
Klawitter et al. [22]. The half-time of γ expression is about
17 hr, when adapted cells are returned to isotonic conditions
[7]. In comparison Na,K-ATPase reached the cell surface in
cultured MDCK cells 50 min after synthesis [9], and the
peak of both radioactive-labeled α and β subunits appeared
in the plasma membrane-enriched sample from MDCK cells
at 60 min suggesting that they moved as αβ heterodimers
[26]. Hypertonicity induced increased Na,K-ATPase expres-
sion in MDCK cells as studied by mRNA levels of α and β
subunits, pump activity in cell homogenates and elevated
capacity for active K+ influx [5]. Thus, it is likely that
hypertonicity increased rather than decreased the rate of
synthesis and transport of Na,K-ATPase. Also in IMCD3
cells  α1 may be synthesized and transported to the cell
surface more quickly than γ. Different synthesis and trans-
port times to reach the cell surface are consistent with our
immunocytochemical observations indicating that α and
γ subunits are not transported together, and that γ is trans-
ported alone to the plasma membrane.
The different responses of the γ and α1 subunits to BFA
observed in the present study show that α1 is more tolerant
to BFA than the small γ subunit. Less sensitivity of the α1
subunit to BFA may mean that if trafficking after biosynthe-
sis is inhibited by BFA, α1 will remain unchanged longer in
the plasma membrane than γ, while the plasma membrane
contents of γ will decrease more rapidly, perhaps due to the
different stabilities and turnover rates of the proteins. On the
other hand, slower clearance of α1 from the plasma mem-
brane compared to that of γ, may parallel a lower degree of
neosynthesis, which would explain the invisibility of α1 in
the Golgi apparatus.
The over-all effect of BFA in the present study was a
reduction of cell proliferation in hypertonically challenged
IMCD cells. As demonstrated in previous studies on mam-
malian cells [3, 14, 23, 35; for reviews see 19, 21, 28], the
effects of BFA vary in different cell types and to different
extents. However, they generally include disassembly of
the Golgi stacks into tubules and vesicles, and reversible
inhibition of protein secretion at an early stage in the
secretory pathway. In these changes dissociation of ADP-
ribocylation-factor-1 (ARF1) and the coatomer protein com-
plex-1 (COP-I) from Golgi membranes play an important
role [2, 31]. The present results showed that simultaneous
exposure of IMCD3 cells to hypertonicity and BFA had a
stronger effect on the cells than if they were first hyper-
tonically treated and then received BFA. In this case the γ
synthesis continued and resulted in accumulation of γ in
cytoplasmic vesicles, but γ did not incorporate into the plas-
ma membrane, until BFA was removed from the medium.
As shown in several previous studies, the effects of
BFA on cells are reversible. In the IMCD3 cells γ became
expressed again after the removal of BFA from the hyper-
tonic medium. This expression was even more enhanced
than when the cells were continuously kept in the hypertonic
medium (Fig. 5E versus 5G). The reason for the overexpres-
sion of γ following removal of BFA remains to be estab-
lished.
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